Skip to main content
. 2023 Aug 31;21(3):516–525. doi: 10.9758/cpn.22.1009

Table 1.

Comparison of all characteristics of the patient and control groups

Sociodemographic and clinic characteristics Patient Control p valuea
Age (yr) 37.8 ± 10.4 35.1 ± 7.3 0.185b
Sex 0.497
Female 18 (46.2) 21 (53.8)
Male 21 (53.8) 18 (46.2)
Marital status 0.365
Single 21 (53.8) 17 (43.6)
Married 18 (46.2) 22 (56.4)
Educational status 0.090
Middle school and below 20 (51.3) 11 (28.2)
High school 11 (28.2) 19 (48.7)
University 8 (20.5) 9 (23.1)
Residential area 0.096
District 10 (25.6) 17 (43.6)
City 29 (74.4) 22 (56.4)
Economical situation 0.807
Low 12 (30.8) 12 (30.8)
Middle 22 (56.4) 20 (51.3)
High 5 (12.8) 7 (17.9)
Working status 0.173
Working 15 (38.5) 21 (53.8)
Not working 24 (61.5) 18 (46.2)
The use of cigarettes 0.820
Yes 18 (46.2) 17 (43.6)
No 21 (53.8) 22 (56.4)
The use of alcohol/substance 0.431
Yes 5 (12.8) 2 (5.1)
No 34 (87.2) 37 (94.9)
Family history of mental disorder 0.151
Yes 10 (25.6) 5 (12.8)
No 29 (74.4) 34 (87.2)
Self-mutilation (lifetime) 0.104
Yes 8 (20.5) 3 (7.7)
No 31 (79.5) 36 (92.3)
Suicide attempt (lifetime) 0.003
Yes 10 (25.6) 1 (2.6)
No 29 (74.4) 38 (97.4)
Suicide attempt method 0.364
Injury with a cutting tool 7 (70.0) 0 (0)
With drug 1 (10.0) 1 (100.0)
High jump 1 (10.0) 0 (0)
Other 1 (10.0) 0 (0)
Type of drug -
Mood stabilizer (valproate, lithium, carbamazepine) 20 (51.3) -
Antipsychotics 8 (20.5) -
Multiple (antipsychotics + mood stabilizer) 11 (28.2) -
Chlorpromazine equivalent dose (mg/day) 247.8 ± 120.6 - -
Lithium equivalent dose (mg/day) 697.4 ± 173.5 - -

Values are presented as mean ± standard deviation or number (%).

-, not available.

aChi-square analysis, bStudent’s ttest was performed.